Abstract
The copper-catalysed azide-alkyne cycloaddition was applied to prepare three enantiomeric pairs of heterodimers containing a tacrine residue and a 1,4-dideoxy-1,4-imino-D-arabinitol (DAB) or 1,4-dideoxy-1,4-imino-L-arabinitol (LAB) moiety held together via linkers of variable lengths containing a 1,2,3-triazole ring and 3, 4, or 7 CH2 groups. The heterodimers were tested as inhibitors of butyrylcholinesterase (BuChE) and acetylcholinesterase (AChE). The enantiomeric heterodimers with the longest linkers exhibited the highest inhibition potencies for AChE (IC50 = 9.7 nM and 11 nM) and BuChE (IC50 = 8.1 nM and 9.1 nM). AChE exhibited the highest enantioselectivity (ca. 4-fold). The enantiomeric pairs of the heterodimers were found to be inactive (GI50 > 100 µM), or to have weak antiproliferative properties (GI50 = 84–97 µM) against a panel of human cancer cells.
Author contributions
Conceptualisation, E.L.; methodology, I.C.V. and Ó.L.; funding acquisition, E.L, M.O.S., Ó.L., J.M.P., and J.G.F.B.; investigation, E.L, I.C.V, A.P., M.X.F., and Ó.L.; project administration, E.L.; resources, E.L., Ó.L., M.O.S., J.M.P., and J.G.F.B.; supervision, E.L. and M.O.S.; writing – original draft, E.L., I.C.V.; writing – review & editing, E.L., Ó.L., I.C.V., M.O.S., J.M.P., and J.G.F.B.
Disclosure statement
The authors report no conflicts of interest.